PURPOSE: Ischemia-related processes associated with the generation of inflammatory molecules such as reactive oxygen species (ROS) are difficult to detect at the acute stage before the physiologic and anatomic evidence of tissue damage is present. Evaluation of the inflammatory and healing response early after an ischemic event in vivo will aid in treatment selection and patient outcomes. We introduce a novel near-infrared hydrocyanine molecular probe for the detection of ROS as a marker of tissue response to ischemia and a precursor to angiogenesis and remodeling. The synthesized molecular probe, initially a non-fluorescent hydrocyanine conjugated to polyethylene glycol, converts to a highly fluorescent cyanine reporter upon oxidation. PROCEDURES: The probe was applied in a preclinical mouse model for myocardial infarction, where ligation and removal of a portion of the femoral artery in the hindlimb resulted in temporary ischemia followed by angiogenesis and healing. RESULTS: The observed increase in fluorescence intensity was approximately sixfold over 24 h in the ischemic tissue relative to the uninjured control limb and was attributed to the higher concentration of ROS in the ischemic tissue. CONCLUSIONS: These results demonstrate the potential for non-invasive sensing for interrogating the inflammatory and healing response in ischemic tissue.
PURPOSE:Ischemia-related processes associated with the generation of inflammatory molecules such as reactive oxygen species (ROS) are difficult to detect at the acute stage before the physiologic and anatomic evidence of tissue damage is present. Evaluation of the inflammatory and healing response early after an ischemic event in vivo will aid in treatment selection and patient outcomes. We introduce a novel near-infrared hydrocyanine molecular probe for the detection of ROS as a marker of tissue response to ischemia and a precursor to angiogenesis and remodeling. The synthesized molecular probe, initially a non-fluorescent hydrocyanine conjugated to polyethylene glycol, converts to a highly fluorescent cyanine reporter upon oxidation. PROCEDURES: The probe was applied in a preclinical mouse model for myocardial infarction, where ligation and removal of a portion of the femoral artery in the hindlimb resulted in temporary ischemia followed by angiogenesis and healing. RESULTS: The observed increase in fluorescence intensity was approximately sixfold over 24 h in the ischemic tissue relative to the uninjured control limb and was attributed to the higher concentration of ROS in the ischemic tissue. CONCLUSIONS: These results demonstrate the potential for non-invasive sensing for interrogating the inflammatory and healing response in ischemic tissue.
Authors: Yang Liu; Adam Q Bauer; Walter J Akers; Gail Sudlow; Kexian Liang; Duanwen Shen; Mikhail Y Berezin; Joseph P Culver; Samuel Achilefu Journal: Surgery Date: 2011-05 Impact factor: 3.982
Authors: Chulhong Kim; Todd N Erpelding; Konstantin Maslov; Ladislav Jankovic; Walter J Akers; Liang Song; Samuel Achilefu; Julie A Margenthaler; Michael D Pashley; Lihong V Wang Journal: J Biomed Opt Date: 2010 Jul-Aug Impact factor: 3.170
Authors: Tiffany P Gustafson; Ying Yan; Piyaraj Newton; Daniel A Hunter; Samuel Achilefu; Walter J Akers; Susan E Mackinnon; Philip J Johnson; Mikhail Y Berezin Journal: Medchemcomm Date: 2012-06-01 Impact factor: 3.597
Authors: Haiying Zhou; Sean P Gunsten; Natalia G Zhegalova; Sharon Bloch; Samuel Achilefu; J Christopher Holley; Daniel Schweppe; Walter Akers; Steven L Brody; William C Eades; Mikhail Y Berezin Journal: Cytometry A Date: 2015-03-23 Impact factor: 4.355
Authors: Haiying Zhou; Ying Yan; Xueping Ee; Daniel A Hunter; Walter J Akers; Matthew D Wood; Mikhail Y Berezin Journal: Free Radic Biol Med Date: 2016-09-28 Impact factor: 7.376
Authors: Steven T Wang; Natalia G Zhegalova; Tiffany P Gustafson; Andrew Zhou; Joel Sher; Samuel Achilefu; Oleg Y Berezin; Mikhail Y Berezin Journal: Analyst Date: 2013-06-04 Impact factor: 4.616
Authors: Megan C Prunty; Moe H Aung; Adam M Hanif; Rachael S Allen; Micah A Chrenek; Jeffrey H Boatright; Peter M Thule; Kousik Kundu; Niren Murthy; Machelle T Pardue Journal: Invest Ophthalmol Vis Sci Date: 2015-09 Impact factor: 4.799